tyrosine and Neuromuscular Diseases

tyrosine has been researched along with Neuromuscular Diseases in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernreuther, C; Cronin, SJ; Eggan, KC; Glatzel, M; Hanada, R; Hanada, T; Herbst, R; Ichida, J; Kofler, R; Komnenovic, V; Mair, B; Martinez, J; Mimata, H; Minis, A; Orthofer, M; Penninger, JM; Rainer, J; Sato, F; Tamir, I; Wainger, BJ; Weitzer, S; Woolf, CJ; Yaron, A; Yoshimura, A1
Bernardini, S; Bonaldo, P; Cannata, S; Cardaci, S; Cecconi, F; Ciriolo, MR; De Zio, D; Di Giacomo, G; Ferraro, E; Filomeni, G; Gargioli, C; Grumati, P; Ilari, S; Lauro, F; Maiani, E; Montagna, C; Muscoli, C; Rizza, S1
Goto, K; Hayashi, YK; Kawabe, K; Matsumura, T; Nishino, I; Nonaka, I; Ogawa, M; Tagawa, K; Yamanaka, G1
Clayton, BE; Smith, I; Wolff, OH1

Other Studies

4 other study(ies) available for tyrosine and Neuromuscular Diseases

ArticleYear
CLP1 links tRNA metabolism to progressive motor-neuron loss.
    Nature, 2013, Mar-28, Volume: 495, Issue:7442

    Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Axons; Cell Death; Diaphragm; Embryo Loss; Embryo, Mammalian; Exons; Female; Fibroblasts; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Motor Neurons; Muscular Atrophy, Spinal; Neuromuscular Diseases; Oxidative Stress; Respiration; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Transfer, Tyr; Spinal Nerves; Transcription Factors; Tumor Suppressor Protein p53; Tyrosine

2013
S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunction.
    Antioxidants & redox signaling, 2014, Aug-01, Volume: 21, Issue:4

    Topics: Alcohol Dehydrogenase; AMP-Activated Protein Kinases; Animals; Apoptosis; Atrophy; Autophagy; Forkhead Box Protein O3; Forkhead Transcription Factors; Glutathione Reductase; Mice; Mice, Knockout; Mitochondria; Muscle, Skeletal; Neuromuscular Diseases; NF-E2-Related Factor 2; Nitric Oxide; Oxidation-Reduction; Regeneration; Tyrosine

2014
Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
    Journal of the neurological sciences, 2003, Jul-15, Volume: 211, Issue:1-2

    Topics: Age of Onset; Alanine; Blotting, Western; Calpain; Cysteine; Cytoskeletal Proteins; DNA Mutational Analysis; Dysferlin; Dystroglycans; Dystrophin; Glycine; Humans; Immunohistochemistry; Japan; Membrane Glycoproteins; Membrane Proteins; Muscle Proteins; Muscle, Skeletal; Muscular Dystrophies; Mutation; Neuromuscular Diseases; Sarcoglycans; Sequence Analysis, Protein; Tyrosine

2003
New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.
    Lancet (London, England), 1975, May-17, Volume: 1, Issue:7916

    Topics: Biopterins; Child; Child, Preschool; Deglutition Disorders; Dihydropteridine Reductase; Female; Humans; Infant; Intellectual Disability; Male; Neuromuscular Diseases; Phenylalanine; Phenylketonurias; Seizures; Tyrosine

1975